About Us

NovaTeb Pars, is a knowledge-based research and production complex of biological products and the first manufacturer of animal-derived bone substitutes material the Middle East. It was established in 2014 with the objective of manufacturing medical and dental biomaterial products and is committed to playing a pivotal role in supplying and providing essential biological products to dentists and physicians through the expertise of Iranian specialists and the use of the most up-to-date equipment, technologies, and facilities.

NovaTeb Pars has earned its reputation through hard work, dedication, and continuous process improvement and we consider it our eternal mission to pursue. The superiority of the products manufactured by this company in comparison with other companies is their remarkable quality compared to other similar products. In addition, the company currently employs 20 university graduates directly in production roles, with more than 50 additional personnel engaged indirectly.

NovaTeb Pars Co. with professional experience and by highly trained and expert team, is proud to announce its abilities in design and production of biological products as following list:

  • Xenograft Bone Substitute
  • Collagen Membranes Derived from Bovine Tendon & Pericardium
  • Dental Bleaching Gels Kit (Laser and LED)
  • Dental Canal Disinfection Dyes: Photosensitizing agents including Methylene blue, Toluidine blue, and Indocyanine green
  • Dental Gum Protective Resin
  • Tooth Desensitizer Gel

All the above-mentioned devices are produced in high volume and have the licenses from the Health, Treatment and Medical Instruction Ministry and Industry, Mine and Trade Ministry of Iran along with the ISO13485: 2016 certificate issued by CISQ/IMQ (Italian body) which is about requirements of quality management systems in field of medical devices so products which are provided for the medical community, have desired quality and function. Moreover, the dental canal disinfection dyes and dental bleaching gels kit have received CE mrak from the European Union.

Furthermore, this company has continued research and development efforts to design and manufacture new products. In this regard, products based on bioactive peptides can also be considered among the company’s new products that are currently in the research and development phase